BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14500586)

  • 1. Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization.
    Coombes KR; Fritsche HA; Clarke C; Chen JN; Baggerly KA; Morris JS; Xiao LC; Hung MC; Kuerer HM
    Clin Chem; 2003 Oct; 49(10):1615-23. PubMed ID: 14500586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).
    Hong H; Dragan Y; Epstein J; Teitel C; Chen B; Xie Q; Fang H; Shi L; Perkins R; Tong W
    BMC Bioinformatics; 2005 Jul; 6 Suppl 2(Suppl 2):S5. PubMed ID: 16026602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform.
    Coombes KR; Tsavachidis S; Morris JS; Baggerly KA; Hung MC; Kuerer HM
    Proteomics; 2005 Nov; 5(16):4107-17. PubMed ID: 16254928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS.
    Sauter ER; Shan S; Hewett JE; Speckman P; Du Bois GC
    Int J Cancer; 2005 May; 114(5):791-6. PubMed ID: 15609313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry.
    Pawlik TM; Fritsche H; Coombes KR; Xiao L; Krishnamurthy S; Hunt KK; Pusztai L; Chen JN; Clarke CH; Arun B; Hung MC; Kuerer HM
    Breast Cancer Res Treat; 2005 Jan; 89(2):149-57. PubMed ID: 15692757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer.
    Paweletz CP; Trock B; Pennanen M; Tsangaris T; Magnant C; Liotta LA; Petricoin EF
    Dis Markers; 2001; 17(4):301-7. PubMed ID: 11790897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.
    Brozkova K; Budinska E; Bouchal P; Hernychova L; Knoflickova D; Valik D; Vyzula R; Vojtesek B; Nenutil R
    Breast Cancer Res; 2008; 10(3):R48. PubMed ID: 18510725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid.
    Alexander H; Stegner AL; Wagner-Mann C; Du Bois GC; Alexander S; Sauter ER
    Clin Cancer Res; 2004 Nov; 10(22):7500-10. PubMed ID: 15569980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid.
    Li J; Zhao J; Yu X; Lange J; Kuerer H; Krishnamurthy S; Schilling E; Khan SA; Sukumar S; Chan DW
    Clin Cancer Res; 2005 Dec; 11(23):8312-20. PubMed ID: 16322290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of algorithms for pre-processing of SELDI-TOF mass spectrometry data.
    Cruz-Marcelo A; Guerra R; Vannucci M; Li Y; Lau CC; Man TK
    Bioinformatics; 2008 Oct; 24(19):2129-36. PubMed ID: 18694894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of nipple aspirate fluid throughout the menstrual cycle in healthy pre-menopausal women.
    Noble J; Dua RS; Locke I; Eeles R; Gui GP; Isacke CM
    Breast Cancer Res Treat; 2007 Aug; 104(2):191-6. PubMed ID: 17061038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of acyl-CoA oxidase-deficient and peroxisome proliferator Wy14,643-treated mouse liver protein by surface-enhanced laser desorption/ionization ProteinChip Biology System.
    Chu R; Zhang W; Lim H; Yeldandi AV; Herring C; Brumfield L; Reddy JK; Davison M
    Gene Expr; 2002; 10(4):165-77. PubMed ID: 12174850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers.
    Soltys SG; Le QT; Shi G; Tibshirani R; Giaccia AJ; Koong AC
    Clin Cancer Res; 2004 Jul; 10(14):4806-12. PubMed ID: 15269156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology].
    Guan X; Li DR; Wang Q; Li L; Ruan HY; Zhang W
    Ai Zheng; 2008 Nov; 27(11):1155-60. PubMed ID: 19000445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SELDI-TOF-MS proteomics of breast cancer.
    Clarke CH; Buckley JA; Fung ET
    Clin Chem Lab Med; 2005; 43(12):1314-20. PubMed ID: 16309366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.
    Semmes OJ; Feng Z; Adam BL; Banez LL; Bigbee WL; Campos D; Cazares LH; Chan DW; Grizzle WE; Izbicka E; Kagan J; Malik G; McLerran D; Moul JW; Partin A; Prasanna P; Rosenzweig J; Sokoll LJ; Srivastava S; Srivastava S; Thompson I; Welsh MJ; White N; Winget M; Yasui Y; Zhang Z; Zhu L
    Clin Chem; 2005 Jan; 51(1):102-12. PubMed ID: 15613711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers.
    Rai AJ; Stemmer PM; Zhang Z; Adam BL; Morgan WT; Caffrey RE; Podust VN; Patel M; Lim LY; Shipulina NV; Chan DW; Semmes OJ; Leung HC
    Proteomics; 2005 Aug; 5(13):3467-74. PubMed ID: 16052624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.